Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 07
2023
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+15.43%
|
$0
$0.94 P/Share
|
|
Aug 04
2023
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+18.25%
|
$0
$0.94 P/Share
|
|
Jul 31
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-2.83%
|
$153,410
$290.47 P/Share
|
|
Jul 31
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+9.63%
|
$16,000
$16.0 P/Share
|
|
Jul 24
2023
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+22.32%
|
$0
$0.94 P/Share
|
|
Jul 24
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-2.98%
|
$160,816
$304.99 P/Share
|
|
Jul 24
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+10.09%
|
$16,000
$16.0 P/Share
|
|
Jul 17
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-3.14%
|
$172,454
$326.84 P/Share
|
|
Jul 17
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+10.59%
|
$16,000
$16.0 P/Share
|
|
Jul 17
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
65
+1.29%
|
$21,125
$325.91 P/Share
|
|
Jul 17
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.2%
|
$13,000
$325.91 P/Share
|
|
Jul 17
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+3.36%
|
$14,950
$325.91 P/Share
|
|
Jul 17
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+1.49%
|
$14,950
$325.91 P/Share
|
|
Jul 17
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+3.53%
|
$13,650
$325.91 P/Share
|
|
Jul 17
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40
+4.41%
|
$13,000
$325.91 P/Share
|
|
Jul 10
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-3.33%
|
$163,990
$310.42 P/Share
|
|
Jul 10
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+11.15%
|
$16,000
$16.0 P/Share
|
|
Jul 03
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-3.54%
|
$170,338
$322.09 P/Share
|
|
Jul 03
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+11.77%
|
$16,000
$16.0 P/Share
|
|
Jun 26
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-3.78%
|
$166,635
$315.87 P/Share
|
|
Jun 26
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+12.46%
|
$16,000
$16.0 P/Share
|
|
Jun 20
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-4.05%
|
$162,403
$307.64 P/Share
|
|
Jun 20
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+13.24%
|
$16,000
$16.0 P/Share
|
|
Jun 12
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-4.37%
|
$163,461
$309.03 P/Share
|
|
Jun 12
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.12%
|
$16,000
$16.0 P/Share
|
|
Jun 05
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-4.74%
|
$161,345
$305.69 P/Share
|
|
Jun 05
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+15.12%
|
$16,000
$16.0 P/Share
|
|
May 30
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-5.17%
|
$155,526
$294.9 P/Share
|
|
May 30
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+16.28%
|
$16,000
$16.0 P/Share
|
|
May 22
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-5.7%
|
$162,403
$307.52 P/Share
|
|
May 22
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+17.63%
|
$16,000
$16.0 P/Share
|
|
May 15
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-6.34%
|
$154,997
$293.91 P/Share
|
|
May 15
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+19.23%
|
$16,000
$16.0 P/Share
|
|
May 12
2023
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
4,525
-20.94%
|
$1,321,300
$292.86 P/Share
|
|
May 12
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,525
+33.72%
|
$321,275
$71.0 P/Share
|
|
May 08
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-7.15%
|
$148,120
$280.0 P/Share
|
|
May 08
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+21.15%
|
$16,000
$16.0 P/Share
|
|
May 08
2023
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,727
-28.32%
|
$483,560
$280.12 P/Share
|
|
May 08
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,727
+22.07%
|
$72,534
$42.15 P/Share
|
|
Apr 27
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+3.2%
|
-
|
|
Apr 27
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+34.36%
|
-
|
|
Apr 27
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
669
+44.69%
|
-
|
|
Apr 27
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+18.27%
|
-
|
|
Apr 27
2023
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+3.14%
|
-
|
|
Apr 27
2023
|
Jerry C Griffin Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+19.69%
|
-
|
|
Apr 27
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+12.03%
|
-
|
|
Apr 27
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+37.67%
|
-
|
|
Apr 27
2023
|
Shawn Mc Cormick Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+5.2%
|
-
|
|
Apr 27
2023
|
Cynthia Burks Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+50.0%
|
-
|
|
Apr 25
2023
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
8,000
-27.58%
|
$2,168,000
$271.49 P/Share
|